Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3053050 | 0.85 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBHSD11B1 | |
| SCHEMBL1310160 | 0.80 | ALDH1A1 (0.42) | ALDH1A1TSHRTHRBHSD11B1 | |
| SCHEMBL75487 | 0.78 | ALDH1A1 (0.41) | ALDH1A1TSHRTHRBHSD11B1 | |
| SCHEMBL15928282 | 0.78 | ALDH1A1 (0.41) | ALDH1A1TSHRTHRBHSD11B1 | |
| SCHEMBL12266595 | 0.78 | ALDH1A1 (0.34) | ALDH1A1TSHR | |
| SCHEMBL23377974 | 0.78 | ALDH1A1 (0.38) | ALDH1A1TSHRTHRB | |
| SCHEMBL75649 | 0.76 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBHSD11B1 | |
| SCHEMBL685781 | 0.75 | ALDH1A1 (0.36) | ALDH1A1TSHRTHRB | |
| SCHEMBL22811898 | 0.75 | HSD11B1 (0.51) | ALDH1A1TSHRTHRBHSD11B1 | |
| SCHEMBL17247226 | 0.74 | ALDH1A1 (0.36) | ALDH1A1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100266954-A1 | ADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND CURING COMPOSITION CONTAINING ADAMANTANE DERIVATIVE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100266954-A1 | ADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND CURING COMPOSITION CONTAINING ADAMANTANE DERIVATIVE | APP, TET1, AMD1 | ALDH1A1 8/4885TSHR 4139/4885THRB 3702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.